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Summary
Background: Patients with acute coronary syndrome (ACS) frequently present with typical chest
pain; however a considerable proportion may present with atypical symptoms.
Objective: The purpose of this study was to evaluate the prognostic value of different presenting
symptoms in ACS patients.syndrome Methods: Over a 5-month period in 2007, 6704 consecutive patients presenting with ACS were
enrolled and categorized into three groups according to their presenting symptom (typical chest
pain, atypical chest pain, and dyspnea). Data were collected from a prospective, multicenter,
multinational, observational study from 6 countries. The baseline characteristics, therapy, and
analyzed and compared in the three groups.in-hospital outcomes were
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Results: In comparison to typical chest pain, patients with atypical pain or dyspnea were older
and had more cardiovascular risk factors. These two groups were signiﬁcantly less likely to receive
evidence-based therapy and coronary angiography and suffered worse in-hospital outcomes. The
mortality rates were 3%, 2.5%, and 6% in patients presenting with typical, atypical chest pain,
and dyspnea, respectively. After adjustment for confounders, the absence of typical chest pain
was associated with higher mortality rate (odds ratio 2.0, 95% conﬁdence intervals 1.29—2.75).
Conclusions: Across ACS, patients presenting without chest pain were frequently underesti-
mated, less well treated with evidence-based therapy, and had worse in-hospital outcomes.
Clinical presentation of ACS may provide additional prognostic impact particularly in high-risk
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covariates (age, sex, diabetes mellitus, and blood pres-
sure) among patients in the three groups. In addition,populations.
© 2011 Japanese College of C
ntroduction
ew studies have highlighted the clinical signiﬁcance and
utcome of acute coronary syndrome (ACS) in patients pre-
enting with or without typical chest pain [1—4]. Heberden
as the ﬁrst to describe typical ischemic chest pain while
he concept of atypical chest pain remains more elusive with
o standard deﬁnition. However, the generally used deﬁ-
ition of atypical chest pain is any chest pain that does
ot meet Heberden’s classic description [5,6]. Breathless-
ess (dyspnea) alone can be the presenting symptom of ACS
nd was found to be present in 26% of patients. In another
tudy, among 8.4% of the patients who presented without
hest pain, nearly half of them had dyspnea only. Patients
ith dyspnea or with other painless presentations of ACS
ad worse outcomes [7,8]. In comparison to ST-segment
levation myocardial infarction (STEMI), patients with non-
T-segment elevation ACS (NSTEACS) represent the majority
f ACS patients (≈67%), however, data on the impact of
typical presenting symptoms in those patients are scarce
9—11]. Herein, we evaluate the prognostic value of the
ifferent presenting symptoms in patients with ACS (STEMI
nd NSTEACS). Patients’ characteristics and hospital out-
omes are described and compared among the three groups
f patients presenting with typical and atypical chest pain
nd dyspnea.
ethods
eﬁnition and data analysis
he data were collected from a 5-month prospective,
ulticenter study of the Gulf Registry of Acute Coronary
vents (Gulf RACE) in 2007. The study recruited 6704 con-
ecutive ACS patients from 6 Middle Eastern countries
Bahrain, Kuwait, Qatar, Oman, United Arab Emirates, and
emen). The rationale and details of Gulf RACE have been
escribed previously [12,13]. Brieﬂy, Gulf RACE aimed to
dentify the characteristics, clinical management, and hos-
ital outcomes of ACS patients [STEMI and NSTEACS (NSTMI
nd unstable angina)]. Diagnosis of the different types
f ACS and deﬁnitions of data variables were based on
he American College of Cardiology clinical data standards
12—14]. Data on patient clinical characteristics, electrocar-
iographic ﬁndings, biochemical markers and therapy were
ollected by the attending physician in the accident and
mergency department. At discharge, major adverse clin-
cal events (re-ischemia, heart failure, cardiogenic shock,
troke, and mortality) were recorded.
m
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aology. Published by Elsevier Ltd. All rights reserved.
tudy groups
he deﬁnition of symptoms was prespeciﬁed in the registry
nd data were collected prospectively. For this analysis,
egardless of the electrocardiographic changes, patients
ere divided into three groups depending on the nature
f their predominant presenting symptom [9,15,16]. Group
: The ‘‘typical’’ symptoms of myocardial ischemia include
1) precordial chest discomfort, pain, heaviness, or fullness,
ossibly radiating to the arm, shoulder, back, neck, jaw, epi-
astrium, or other location;(2) symptoms exacerbated by
xertion or stress; (3) symptoms that may be relieved by
est or use of nitroglycerin; and (4) symptoms associated
ith shortness of breath, diaphoresis, weakness, nausea
r vomiting, and light-headedness. Group 2: ‘‘Atypical’’
hest pain has been described as not severe; not prolonged;
ot classic in presentation; not exactly like prior cardiac
ymptoms; a burning, sharp, pleuritic, positional pain or
iscomfort that is reproducible on palpation of the chest
all and localizable by one ﬁnger; or pain or discomfort in
reas of the upper body other than the chest, such as the
rms, epigastrium, shoulder, and neck. Group 3: Dyspnea:
he predominant complaint is sudden onset of unexplained
hortness of breath. In the current analysis, we excluded
atients who presented mainly with cardiac arrest, loss of
onsciousness, palpitation, generalized body aches, easy
atigue, or epigastric discomfort.
tatistical analysis
ifferences in patient characteristics, management, and
utcomes between the three groups were assessed using
ontinuous variables summarized as median and interquar-
ile ranges. Categorical variables are summarized as
ercentages, and compared using Chi square tests. In a
ubanalysis, atypical chest pain and dyspnea groups were
athered into one group (absent typical chest pain) and
ompared to the typical chest pain group. Step-wise multi-
ariate logistic regression was used to identify independent
redictors of in-hospital mortality adjusted for baselineultivariate analysis was used to determine the predic-
ors of the type of the presenting symptoms. A p-value
f <0.05 was considered statistically signiﬁcant. SPSS 14.0
SPSS Inc., Chicago, IL, USA) statistical package was used for
nalysis.
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Table 1 Baseline characteristics, clinical presentations, management, and outcomes in patients with acute coronary syndrome
stratiﬁed by the presenting symptom.
Typical pain (n = 5349; 83%) Atypical pain (n = 401; 6%) Dyspnea (n = 670; 11%) p-Value
Risk factors
Age (mean, years) 55± 12 57± 13 64± 11 <0.001
Female sex 22% 28% 38% <0.001
Family history of CAD 13% 15% 18% 0.001
Diabetes mellitus 38% 39% 63% <0.001
Hypertension 47% 55% 72% <0.001
Dyslipidemia 31% 25% 46% <0.001
Smoking 41% 32% 25% <0.001
Obesity 25% 22% 35% 0.001
Renal failure 15% 17% 37% <0.001
Prior CAD 44% 40% 63% <0.001
Prior revascularization 15% 16% 19% 0.03
COPD 4.4% 6.8% 12% 0.001
Biochemical and clinical proﬁles
Heart rate 83± 20 86± 21 103± 24 <0.001
Systolic blood pressure 139± 28 140± 26 151± 39 0.001
Diastolic blood pressure 84± 17 83± 16 88± 22 <0.001
Peak troponin (ng/L) 18± 52 11± 42 8± 41 <0.001
1st blood sugar (mmol/L)* 11± 10 10± 6 14± 13 <0.001
1st creatinine (mmol/L)* 104± 90 106± 81 130± 109 <0.001
Total cholesterol (mmol/L) 5± 2 5± 1.4 5± 1.4 0.02
Triglyceride (mmol/L) 2± 2 2± 8 2± 1.5 0.009
1st hemoglobin (g/dl)* 14± 4 14± 5 13± 6 <0.001
Symptom>12 h 28% 50% 61% <0.001
Low GRACE scoring 47% 44% 6% <0.001
High GRACE scoring 24% 31% 78% <0.001
LVEF < 40% 18% 18% 53% <0.001
ST-elevation MI 43% 27% 18% <0.001
NSTEACS 57% 73% 82% <0.001
Hospital stay 5.5± 4 5.4± 4 6.6± 7 0.001
All continuous variables are given as mean± SD. CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; GRACE,
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pGlobal Registry of Acute Coronary Events; LVEF, left ventricular ej
acute coronary syndrome.
* The value of ﬁrst measurement.
Results
Study population
The study enrolled 6704 consecutive patients presenting
with ACS whereas the inclusion criteria were fulﬁlled in
6420 patients. On admission, 5349 patients (83%) had typical
chest pain, 401(6%) had atypical chest pain, and 670 (11%)
had dyspnea. Patients who had different presentations (284
patients) such as loss of consciousness (1.1%), palpitation
(1.1%), others (2%) (i.e. generalized body aches, easy fati-
gability, or epigastric discomfort) were excluded from the
current analysis.
Table 1 summarizes the baseline biochemical and clin-
ical proﬁle in the three groups. Patients who presented
with atypical pain or dyspnea were older compared to those
with typical angina. They were more likely to be females
and to have more cardiovascular risk factors. On admission,
patients with dyspnea had signiﬁcantly higher resting heart
rate, systolic and diastolic blood pressure, and greater val-
ues of on-admission blood sugar and creatinine. Delay to
I
A
i
on fraction; MI, myocardial infarction; NSTEACS, non-ST-elevation
eek medical care for more than 12 h was frequently seen in
he dyspnea and atypical chest pain groups in comparison to
he typical chest pain group (61% vs 51% vs 28%; p < 0.001).
ig. 1A demonstrates the breakdown of the presenting symp-
oms in STEMI and NSTEACS. Atypical presentation of ACS
as high in patients with chronic obstructive pulmonary dis-
ase (COPD) when compared to patients without COPD (36%
s 19%; p < 0.001).
redictors of the presenting symptoms
ig. 2 shows the predictors of the presenting symptoms in
CS patients. Predictors of the absence of typical chest pain
t presentation included female gender, higher heart rate,
iabetes mellitus, renal failure, high Killip class, and late
resentation.n-hospital management
fter hospital admission, there were differences in the med-
cal and invasive management provided to patients based
n their presenting symptoms. In-hospital coronary angiog-
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Sigure 1 (A) The presenting symptoms across acute coronary
nfarction (STEMI) and non-ST elevation acute coronary syndrom
aphy was performed less frequently in patients with absent
hest pain (Table 2). Patients with absent typical chest pain
ere also less likely to receive thrombolytic therapy and had
elayed door to needle time (99 vs 55min; p < 0.001). This
roup was also less likely to undergo percutaneous coronary
ntervention (3% vs 5%; p < 0.001) and to receive antiplatelet
herapy, beta-blockers, heparin, and statins.
i
p
u
a
igure 2 Predictors of symptom presentation in acute coronary sy
T-elevation myocardial infarction.drome (ACS) and (B) mortality rate in ST-elevation myocardial
STEACS) according to the presenting symptoms.
n-hospital outcomes
n comparison to patients presenting with typical angina,
n-hospital outcomes were worse in those with absent chest
ain in the form of signiﬁcantly higher rates of heart fail-
re, cardiogenic shock, stroke, and mortality (Table 2). After
djustment for confounders, absence of typical chest pain
ndrome. HR, heart rate; CAD, coronary artery disease; STEMI,
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Table 2 In-hospital therapy and outcomes.
Typical pain Atypical pain Dyspnea p-Value
In-hospital therapy
Aspirin 98% 96% 96% <0.001
Clopidogrel 57% 49% 36% <0.001
Glycoprotein inhibitors 11% 10% 7% <0.001
Heparin 94% 91% 86% 0.001
ACE inhibitors 69% 64% 80% <0.001
Beta blockers 72% 64% 22% <0.001
Statins 82% 83% 79% 0.001
Coronary angiogram 20% 17% 9% <0.001
In-hospital outcomes
Re-ischemia 9% 10% 8% 0.75
Heart failure 12% 11% 55% <0.001
Cardiogenic shock 4% 3% 10% <0.001
Stroke 0.5% 2.5% 0.8% 0.001
Major bleeding 0.6% 1.3% 1.0% 0.001
Mortality 3% 2.5% 6% <0.001
D
T
t
pACE, angiotensin-converting enzyme.
was associated with a higher mortality rate (odds ratio 2.0,
95% conﬁdence intervals 1.29—2.75) (Table 3). The mortal-
ity rate was even higher in patients presenting with dyspnea
when compared to other groups (Fig. 1B). Also, prolonged
hospitalization was more evident in this group (5.5± 0.05
vs 6.0±0.13 days; p < 0.001). Fig. 3 highlights the impact of
age, sex, diabetes mellitus, and renal failure on the mor-
tality rate based on whether the patients presented with
typical chest pain or not.
s
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Figure 3 In-hospital mortality according to symptom presentation
i.e. diabetes or renal failure (B).iscussion
he current study represents one of the largest observa-
ional studies comparing the impact of symptoms at the
resentation of ACS on patient outcomes. Atypical pre-
entation of ACS was reported in several studies ranging
rom 4.7% to 33% and was associated with worse outcomes
1,4,8,9,17,18]. The current study supports these observa-
ions and reports for the ﬁrst time the clinical predictors
stratiﬁed by age and sex (A) and the presence of co-morbidities
170
Table 3 Multivariate analysis of the predictors of in-
hospital mortality.
OR 95% CI p-Value
Absent typical chest pain 2.0 1.29—2.75 0.001
Diabetes mellitus 1.4 1.03—2.06 0.03
Beta blockers 0.30 0.21—0.43 <0.001
Thrombolytic therapy 0.45 0.31—0.65 <0.001
ACE inhibitors 0.36 0.25—0.50 <0.001
Aspirin 0.24 0.12—0.48 <0.001
Clopidogrel 0.94 0.67—1.32 0.73
Glycoprotein inhibitors 0.42 0.16—1.10 0.07
Variables are adjusted for age, sex, heart rate, and blood
pressure.
OR, odds ratio; CI, conﬁdence interval; ACE, angiotensin-
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f the absence of typical chest pain in ACS. Women were
ore likely to present with atypical symptoms in compari-
on to men and this gender gap had negative impact on the
urvival rate [13].
The type and severity of symptoms that occur with ACS
epend on the type and number of nociceptive afferent
erves activated and these afferent impulses may stimu-
ate efferent impulses in the autonomic nervous system to
roduce symptoms [19]. The sex differences in ACS presen-
ation may relate to different incidences of neuropathies.
he incidence of neuropathies increases with advancing age,
ncreasing body mass index, and a history of diabetes melli-
us. In diabetes mellitus, autonomic neuropathy is common,
nd tends to affect the vagal nerves before it affects the
ympathetic nerves [19]. Diabetic patients represented 50%
f the atypical presentation group and this subset of popu-
ation was associated with higher mortality rate particularly
hen dyspnea was the principal presentation [20]. Dyspnea
lone can be the presenting symptom in 26—49% of patients
ith ACS [7—9,20]. In the present study, the mortality rate
ncreased 3 times in STEMI and NSTEACS when patients pre-
ented with dyspnea. Patients presenting with dyspnea were
lder, being female, more likely to have cardiovascular risk
actors and higher heart rate and systolic blood pressure on
resentation, lower left ventricular ejection fraction and
reater in-hospital complications such as cardiogenic shock.
ccording to Table 2 and Fig. 1B, we may conclude that dys-
nea is the most important presenting symptom associated
ith worse hospital outcomes.
Furthermore, symptoms of ACS may be affected by the
resence of certain traditional risk factors [14,21—23]. Con-
istent with prior studies, our study demonstrated that
atients presenting with dyspnea had greater morbidity and
ortality as they were more likely to be older, females and
iabetics. Patients with renal failure were more likely to
resent without typical angina and to be associated with
igher mortality rate. Furthermore, the extent of infarcted
yocardium may also inﬂuence the symptoms at presenta-ion [15,22]. This may be related to a lower frequency of
hest pain among those with evolving NSTEMI (57% vs 77%)
han among those with evolving STEMI (43% vs 23%) in the
urrent study.A. El-Menyar et al.
Our study demonstrated that atypical presentation of ACS
s a signiﬁcant independent predictor of in-hospital mor-
ality after adjusting for measurable covariates. Previous
tudies that utilized different risk scores did not demon-
trate the impact of the predominant presenting symptom
n the short-term outcome in patients with ACS [24]. In the
resent study, the majority of patients with absent chest
ain ranked high Global Registry of Acute Coronary Events
isk scoring [24]. Our study highlighted that clinical presen-
ation of ACS may have an additional prognostic impact.
The delay in seeking medical advice, improper medical
ssessment, inappropriate patients’ disposition, and delay
o give the evidence-based therapy in ACS was frequently
ncountered in patients who did not appreciate the typi-
al symptoms of ACS. The mortality rate observed in AMI
atients presenting without chest pain was attributed to
he delay and underuse of optimal therapies [1]. The current
tudy strongly advocates the role of the front-line physicians
o consider the diagnosis of ACS even in the absence of typ-
cal symptoms, to set the appropriate management without
elay, and not to deprive patients with STEMI from reperfu-
ion therapy based on the absence of typical presentation
1].
imitations
ur data were collected from an observational study which
s one of the limitations. However, well-designed observa-
ional studies provide valid results and do not systematically
verestimate the results compared with the results of ran-
omized controlled trials. As our data were demonstrated in
speciﬁc ethnic population, the results cannot be general-
zed; however, similar results were reported from different
thnicities [1,4,8,9,17,18].
onclusion
typical presentation has a negative impact on the care and
utcomes of patients with ACS, and therefore, it should not
imit our decision making and management strategies par-
icularly in high risk patients, i.e. diabetes mellitus, renal
ailure, old age, and COPD. Patients with ACS who present
ithout typical angina are frequently undertreated. Clinical
resentation may be an important added prognostic factor
or patient risk stratiﬁcation.
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